We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£107.98
Springer Hepatitis C Virus Disease: Immunobiology and Clinical Applications
Price data last checked 45 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£108 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 46 days · 46 data points (no recent data)
Price Distribution
Price distribution over 46 days • 1 price levels
Price Analysis
Most common price: £108 (46 days, 100.0%)
Price range: £108 - £108
Price levels: 1 different prices over 46 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1441924388
- Domain
- Amazon UK
- Release Date
- 29 October 2010
- Listed Since
- 14 June 2010
Barcode
No barcode data available
Similar Products You Might Like
Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)
Elsevier
Hepatitis C in Developing Countries: Current and Future Challenges
Academic Press
Hepatitis C Virus II: Infection and Disease: 2
Springer
Hepatitis C Virus II: Infection and Disease: 2
Springer
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future
Springer
Hepatitis C: Antiviral Drug Discovery and Development
Caister Academic Press Limited
Immune Response of HCV Infected Patients to Virus Peptides: Immune Response, antiviral therapy, ELISPOT, 4a, core peptides, ribavirin
LAP Lambert Academic Publishing
Hepatitis C Virus: From Molecular Virology to Antiviral Therapy: 369 (Current Topics in Microbiology and Immunology, 369)
Springer
Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)
Thieme
Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance
Springer
Hepatitis B Virus Infection: Molecular Virology to Antiviral Drugs: 1179 (Advances in Experimental Medicine and Biology, 1179)
Springer
Chronische Virushepatitis und ihre Behandlung mit Interferon alfa
Springer
Chronic Viral Hepatitis: Diagnosis and Therapeutics (Clinical Gastroenterology)
Humana
Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)
Humana
Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)
Elsevier
Medication of HCV:Revolution of Direct Antiviral Agents and Sofosbuvir: Management of Chronic Hepatitis C:The Revolution of Direct Antiviral drugs(DAAs) and its Backbone; Sofosbuvir
LAP Lambert Academic Publishing
The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)
Wiley-Blackwell
Price unavailable
Humana Hepatitis B and D Protocols Vol 1 - Detection and Genotypes
Humana
Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 19-4) (The Clinics: Internal Medicine, Volume 19-4)
Elsevier
Humana Hepatitis B and D Protocols Vol 2 - Medical Book
Humana
Humana Hepatitis B and D Protocols Vol 2 - Methods in Molecular Medicine
Humana
Chronic Viral Hepatitis: Management and Control
Foster Academics
Novel and Combination Therapies for Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 17-1) (The Clinics: Internal Medicine, Volume 17-1)
Elsevier
A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
National Academies Press